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I. INTRODUCTION
Arthritis is a collective term encompassing many diseases with distinct etiologies but common 
symptoms, such as joint pain and inflammation. Osteoarthritis (OA) and rheumatoid arthritis 
(RA) are both common forms of arthritis despite of the substantial differences in their 
etiology and pathomechanism. Although epidemiological studies have revealed both 
endogenous and exogenous risk factors for OA, it is basically a degenerative joint disease, 
initiated by an injury or repetitive joint stress of the joint.  The mechanical damage activates 
mechanosensitive intracellular signalling in cartilage, which involves the activation of 
inflammatory processes that may develope structural and symptomatic course of disease. 
With regards to the etiology, RA is considered as a multifactorial, multigenic autoimmune 
disease. Although the exact pathomechanism is still unknown, the importance of genetic 
predisposition has been revealed, as polymorphisms of the HLA-DR4 and DR1 locus and 
cytokine genes have been associated with RA. As a result, abnormal activation, adhesion and 
migration of T- and B-lymphocytes and macrophages occur, which is accompanied by 
increased proinflammatory cytokine production (TNF-α, IL-1). As a consequence of the 
chronic autoimmune inflammation, intensive angiogenesis and pannus formation in the 
synovium and cartilage damage may develop. 
Beside these well-known factors in the pathogenesis of arthritis, a growing body of evidence 
suggests the role of mitochondrial damage and dysfunction in synoviocytes and chondrocytes 
of OA and RA patients. On the one hand, mitochondrial dysfunction has been implicated in 
the pathogenesis of primary and post-traumatic OA. On the other hand, some haplogroups of 
mitochondrial respiratory genes are closely associated with higher prevalence of OA and RA 
meaning an increased genetic predisposition to the development of arthritis. As a consequence 
of the altered mitochondrial genes, mitochondrial respiratory activity is impaired in arthritis. 
Today, the “gold standard” therapy for alleviating arthritis-related pain is diclofenac, a 
nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class. Unfortunately, 
the side effects of such an effective compound are also significant. Habitual use of diclofenac 
is associated with the NSAID category risk of dose-related gastrointestinal, cardiovascular, 
and renal adverse effects; consequently, topical preparations were developed to limit the 
potentially serious complications of systemic treatments. The absorption of the topically 
applied diclofenac dose is 3-5 % of the oral formulation and the dose reaches the site of action 
ten times later than the oral dose. New dosing regimens are required to achieve adequate local 
drug concentrations directly at the site of application. Different penetration techniques have 
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been developed to increase bioavailability and transdermal drug delivery, including 
ultrasound and EP. Upon EP, the applications of short, high voltage pulses cause transitory 
structural perturbations in the lipid bilayer of the membranes. In this way, lipophylic or 
hydrophylic molecules, neutral or highly charged compounds can be transported across or into 
the membranes of bacteria or mammalian cells up to 40 kDa molecular weight. Common 
fields of indication for EP are biological and artificial membranes, but it can also be used on 
complex structures such as the synovium.  
After the exhaustion of conservative therapeutic options, resurfacing arthroplasty and 
prostheses for total knee arthroplasty (TKA )are recommended as treatment options for people 
with end-stage arthritis of the knee. Cemented fixation of prosthesis stems is widely used in 
all patients and is the gold standard for TKA. However, observed signs of osteolysis at the 
cement–bone interface has raised questions about the long-term durability of cemented TKAs. 
Therefore, cementless TKAs have been developed with several coating materials. Among 
them, hydroxyapatite (HA)-coating was a promising coating material with the potential to 
achieve biological fixation of implants.  There are several studies comparing the outcomes of 
TKA using HA-coated and non-HA coated prosthesis stems but with conflicting results. This 
can only be answered by a randomized trial comparing the two methods of fixation. 
2. MAIN GOALS OF THE STUDIES
Our main goal in these studies was to characterize the pathomechanism of the main groups of 
arthritic disorders, namely the OA and RA, and to find optimal conservative and operative 
treatments.
 As a first step, in study I., we characterized the mitochondrial changes in the synovial 
membrane in OA and RA patients. For this purpose, we used intraoperative samples, that 
were subjected to HRR, biochemical analysis and histology.
 Then, in study II., we aimed to improve the efficacy of transdermal drug delivery in 
conservative treatment of arthritis. We hypothesized that EP can amplify the transport of 
topical diclofenac into the joints and thus the effectiveness of local administration 
increases. Our aims were to compare the penetration properties of diclofenac hydrogel into 
the synovial fluid after different administration routes, and to estimate the analgesic and 
anti-inflammatory reactions after oral and topical drug deliveries in a standardized rat 
model of carrageenan-kaolin (C/K)-induced knee joint monoarthritis.
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 Our final aim was to investigate the current innovations of prosthesis implantation in the 
operative treatment of arthrosis. Therefore, we conducted a meta-analysis to compare the 
outcomes of TKA using HA-coated and non-HA coated prosthesis stems. The main 
purpose was to update current knowledge and compare data evidence on the quality of 
fixation of the tibial component evaluated with radiostereometric analysis (RSA) in TKA 
under two conditions: with HA-coated cementless prosthesis, or with non-coated 
cementless or cement fixation. RSA is able to accurately measure early migration of the 
stem and maximum total point motion (MTPM), which is the 3-dimensional vector of 
micromotions, has a predictive value of future loosening as primary outcome in our 
analysis. The secondary endpoints were clinical outcomes of TKAs including the Knee 
Society score (KSS) and the Knee Functional score (KFS), which are validated scoring 
systems for measuring the ability of the patient to function in everyday living and assessing 
the magnitude of tolerated pain. Other outcomes, such as the Hospital for Special Surgery 
(HSS) score were also evaluated together with the characteristics of donors and recipients.
3. MATERIALS AND METHODS
3.1. Protocol in Study I.
Prospective clinical study was conducted at a single, level I trauma centre (Department of 
Traumatology at the University of Szeged) between 01 September 2019 and 30 November 
2020. Data were collected from consecutive adult patients (age > 18 years) with signed 
informed consent undergoing open or arthroscopic knee or hip joint surgery. Participants were 
allocated into RA, OA and control groups based on their medical documentation, 2010 
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 
rheumatoid arthritis classification criteria and Kellgren-Lawrence (KL) classification.
Synovial fluid and tissue samples for mitochondrial functional and biochemical analysis 
and hystology from the synovium of RA, OA and control patients were taken intraoperatively 
with the permission and signed consent of the patients. 
3.1.1. Mitochondrial functional measurements and cytochorme c release
The tissue samples were homogenized in 200 µl of MiRO5 respiration medium, then the 
homogenates were weighed into the detection chambers, 50 µl in each, which were calibrated 
to 200 nmol/ml oxygen concentration in room air. Substrates as glutamate (10 mM) and 
malate (2 mM), succinate (10 mM), ADP (5 mM)  and inhibitors as rotenone (0.5 μM) and 
oligomycin (1 mM)  and the uncoupler carbonyl cyanide p-trifluoromethoxy-phenyl-
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hydrazine (FCCP) (0.5 μM) were added to the medium. The intactness of the inner 
mitochondrial membrane was assessed after adding cytochrome C (10 μM).
3.1.3. Inflammatory enzyme activities and cytokine production
Tissue xanthine oxidoreductase (XOR) and myeloperoxidase (MPO) activity and free 
nitrotyrosine, as a marker of peroxynitrite generation, were measured by enzyme-linked 
immunosorbent assay. Pro-inflammatory cytokine (TNFα, RANKL) levels were measured in 
the synovial fluid samples using commercially available ELISA kit according to the 
manufacturer’s instruction.
3. 1.4. Histology
Intraoperatively harvested synovium biopsies were assessed with light microscopy and 
confocal imaging with a laser scanning endomicroscope (CLSM) to validate the proper 
assignment of participants to study groups. 
3.2. Protocol in Study II.
This study was performed in three experimental series. The goal of the first experimental 
series was to assess the serum and the synovial concentrations of topically applied or EP-
enhanced topical diclofenac by high-performance liquid chromatography (HPLC). In the 
second series of experiments, inflammation-related changes to the synovial microcirculation 
were evaluated directly by intravital videomicroscopy (IVM). The animals divided into four 
groups according to the administration route of diclofenac: per os diclofenac in Group 1 
(n=6), with topical diclofenac gel in Group 2, and with EP-combined topical diclofenac gel 
(n=6) in Group 3. Group 4 served as a per os saline-treated control. The treatments were 
always applied 2 h before and 2 h after the arthritis induction.
In the third experimental series, the effectiveness of different routes of diclofenac 
treatment on nociception and inflammatory oedema formation was compared in C/K-induced 
arthritis. The animals were divided into four groups (n=6) according to the administration 
route of diclofenac: (1) per os diclofenac sodium, (2) topical diclofenac gel, (3) EP-enhanced 
topical diclofenac gel and (4) sham (per os saline-treated). Treatments were applied twice 
daily (every 12 h). The nociceptive tests were performed 24 h after the C/K injection, while 
knee joint swelling was evaluated at the peak of oedema formation 48 h after arthritis 
induction. Synovial washing fluid samples and synovium tissue specimens were collected for 
biochemical measurements and histology. 
3.2.1. Arthritis induction
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For arthritis induction a single intra-articular injection of a 75 µL mixture of 2% λ-
carrageenan and 4% kaolin (C/K) in saline was administered to the right knee joint. The 
contralateral knee was injected with saline. This intra-articular injection of C/K is a well-
established model of an acute onset monoarthritis resembling osteoarthritis. In this model, 
arthritis is probably initiated by mechanical damage to the inner surface of the synovium 
resulting in an inflammatory response indirectly to the activation of the endothelial side of the 
synovial barrier.
3.2.2. Electroporation protocols
EP treatment was performed with a Mezoforte Duo Mez 120905-D instrument. 230 µL 
diclofenac hydrogel was used, and the EP treatment time was 8 min.
3.2.3. Diclofenac-containing hydrogel formulation and HPLC measurements
The hydrogel was prepared using the following procedure. 5 w/w% diclofenac sodium  
was dissolved in a mixture of purified water and 30 w/w% ethanol 2 w/w% hydroxypropyl 
methylcellulose was added to this solution. Diclofenac content of the synovial washing fluid 
and plasma samples were analysed using an Agilent HPLC system, equipped with an 
automated solvent delivery system.
3.2.4. Nociceptive tests and knee joint swelling (morphological assessment)
Mechanical hyperalgesia was quantified using a plantar aesthesiometer and was 
expressed as paw withdrawal thresholds. Thermal hyperalgesia was detected with the paw 
withdrawal test using a Hargreaves apparatus. Baseline measurements were performed before 
the induction of arthritis, while the development of inflammation was investigated at the peak 
of nociceptive sensitivity 24 h after C/K injection. Joint inflammation was characterized by 
the changes in the diameter of the joints 48 h after C/K injection. The anteroposterior and 
mediolateral diameters were measured with a caliper square, and the cross-sectional area was 
calculated.
3.2.5. IVM examinations
The presence of adhesion molecules on postcapillary endothelial cells in the 
inflammatory synovial microenvironment has previously been shown and proven to be 
appropriate markers for estimating inflammation. These reactions can be quantitatively 
assessed by IVM, and the efficacy of various therapeutic interventions can also be judged 
objectively. Synovial microcirculation was investigated by means of fluorescent IVM, while 
the synovial membrane was superfused with 37°C saline. Erythrocytes were labelled with 
fluorescent isothiocyanate and leukocytes were stained with rhodamine-6G. 
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3.3. Protocol in Study III. 
A systematic literature search was performed using MEDLINE, Scopus, EMBASE and 
the Cochrane Library databases up to May 31st, 2019. At the end of literature search, 11 
RCTs involving 902 patients for primary TKA were enrolled to analysis. The primary 
outcome was Maximum Total Point Motion (MTPM) of the tibial component. This parameter 
is determined by radiosterometrical analysis and refers to the migration pattern of the 
prosthesis stems. The clinical outcomes of the implanted joints were evaluated by the Knee 
Society Score (KSS) and the Knee Function Score (KFS). We used the Cochrane Risk of Bias 
Tool to assess the risk of bias for each study. 
3.4.13. Statistical analysis
In Study I, the statistical analysis was performed with SigmaStat 13.0 statistical 
software. One-way ANOVA with Tukey’s test was used and the data are expressed as 
mean ± SD. P < 0.05 was considered as statistically significant.
In Study II, data analysis was performed with the SPSS 17.0 software. Changes in variables 
within and between groups were analysed by two-way ANOVA, followed by the Holm–Sidak 
test. All data were expressed as means ± standard deviation of the mean (SD). P values <0.05 
were considered statistically significant.
In Study III, the statistical analysis was performed using Stata 15 SE (Stata Corp). Pooled 
weighted mean difference (WMD) with 95% CI was calculated for continuous outcomes. 
Random effect model was applied at all analysis with DerSimonien-Laird estimation. 
4. RESULTS
4.1. Study I. 
A total of 528 patients underwent hip or knee joint surgery between 01 September l 2019 
and 30 November 2020 at the Traumatology Department of the University of Szeged. 
Inclusion criteria were met in 71 cases, in which 17 patients suffered from RA and 31 from 
OA. The control group consisted of 23 patients under 40 years of age, without a history of OA 
and with a need for surgery due to trauma.
4.1.1. Mitochondrial functional measurements
Changes in mitochondrial respiratory functions were evaluated in the presence of 
glutamate and malate or succinate in order to differentiate between Complex I- and Complex 
II-based activity. Arthritis groups displayed significantly reduced C I activity compared to the 
control group in the presence of saturating amount of ADP. Additionally, OxPhos capacity in 
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the RA group decreased significantly compared to the OA group as well. Respiratory control 
ratio (RCR) and coupling control ratio (CCR) were defined to quantify changes in the 
coupling of the electron transfer chain. In comparison with Control group, Complex I-based 
RCR and CCR both indicated a significant impairment of the electron transfer chain in the RA 
group. However, no significant difference was found in C II-related respiratory activity, RCR 
and CCR between the study groups. OA group exhibited significantly higher Compex I-based 
response to exogenous cytochrome c, while in the RA group both Complex I- and Complex 
II-related activity significantly increased. 
4.1.3. Pro-inflammatory cytokines and oxydoreductive stress markers 
Concentration of RANKL was significantly increased in the RA group compared to the 
control group, while TNF-α levels in the RA group were significantly higher compared to not 
only the control group, but the OA group as well. Significantly higher XOR activities were 
measured in the synovial membrane homogenates of RA and OA patients compared to the 
control group. The synovial tissues of RA patients displayed a significantly higher MPO 
activity compared to the synovial tissues of OA patients and healthy individuals. Significant 
difference in MPO activity occurred also between the OA and control groups. In the RA 
group, significant elevation of NT was present relative to both the OA and control groups.
4.1.5. Histopathology evaluation
CLSEM and H&E staining were used to validate the proper assignment of participants to 
study groups. Histological assessment was performed independently and blindly on coded 
slides by two investigators (P.J. and P.H.) using a previously described 0–4-grade histological 
scoring system, representing a composite of the extent of angiogenesis and fibrosis. 
Additionally, on H&E stained sections, a thickened synovial membrane, increased cellularity 
and mild lymphocytic infiltration occurred in samples from patients suffering from OA. More 
prominent lymphocytic infiltration, fibrosis, and in some cases even extensive fibrosis could 
be observed in RA samples. 
4.2. Study II. 
4.2.1. Plasma and synovial diclofenac concentrations
The plasma and the serum concentrations of diclofenac were the highest 10 min after the 
EP treatment; they then decreased at 30 min and remained constant at 60 and 120 min. EP-
enhanced diclofenac delivery exhibited a significantly higher plasma level of diclofenac as 
compared with the simple topical application 10 min after the application. There were no 
significant differences in the diclofenac content of the synovial fluid and the plasma after the 
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EP-combined application. However, simple topical application did not result in detectable 
diclofenac content in the synovial fluid at the same point in time.
4.2.2. IVM
The PMN–endothelial interactions (rolling and sticking) in the postcapillary venules of 
the synovial membrane were determined. The rolling fraction of the PMNs in the 
postcapillary synovial venules exhibited a large degree of dispersion, and no baseline 
differences were observed between the C/K- and saline-injected knees or between the groups 
which participated in the treatment protocols (data not shown). However, the injection of C/K 
was accompanied by a statistically significant increase in PMN adherence (sticking) to the 
endothelial layer as compared to the control side. This reaction was considerably reduced with 
the administration of oral diclofenac. However, it was only moderately ameliorated by the EP-
enhanced diclofenac hydrogel, and there were no changes in response to the simple topical 
application of the hydrogel.
4.2.3. Inflammatory enzyme activities and cytokine production
XOR and MPO activity and  TNF-α concentration were significantly increased in 
response to arthritis induction, in comparison with the saline-injected knee joint. These values 
were significantly decreased, the oral diclofenac and EP-enhanced topical diclofenac-treated 
groups displayed the same results, however, conventional topical treatment did not influence 
the increased MPO activity.
4.2.4. Nociception and inflammatory oedema
The mechanical touch sensitivity was considerably increased in response to arthritis as 
the C/K-injected limbs responded to a lower level of trigger than the saline-injected control 
limbs in animals receiving the saline vehicle. This parameter was significantly diminished in 
response to oral and EP-enhanced topical diclofenac treatments, albeit complete restoration 
was not achieved. The thermal nociceptive latency was also significantly decreased in the 
injured leg in the saline-treated group, and oral and EP-enhanced topical diclofenac treatments 
exerted similar protective effects to those seen with the von Frey test.
The cross-sectional area in the C/K-injected knees was significantly enlarged 48 h after 
the challenge but was significantly reduced by both the conventional topical and the EP-
enhanced topical diclofenac treatments. In the case of oral diclofenac administration, 
complete restoration to the level for the saline-injected knees was achieved.
4.2.5. Adverse effects of diclofenac intake
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The gastric adverse effects of diclofenac intake were assessed by planimetric analysis of 
ulcers in the gastric mucosa. The topically-applied diclofenac sodium with or without EP had 
no deleterious effect on gastric mucosa; however, an equivalent dose of oral diclofenac 
sodium resulted in ulcer formation in 70% of the animals. The location of gastric ulcerations 
in the rat stomach was variable and included only mild lesions such as oedema, irritation and 
petechia formation.
4.3. Study III. 
Eleven RCTs were included in quantitative synthesis, in which TKA with a HA-coated 
tibial stem was compared to other tibial fixations (cemented and uncemented prosthesis). All 
trials were homogenous with respect to demographic characteristics. 
4.3.1. Radiological outcome
The MTPM of the tibial stem is the primary outcome in this meta-analysis. We used 2 
years follow up for the analysis of the MTPM. The higher MTPM is associated with lower 
stability of the implant with a 0,2 mm cut-off value. Accordingly, if the MTPM exceeds 0,2 
mm, the prosthesis is classified as unstable, which greatly increases the likelihood of other 
complications such as aseptic loosening. If the MTPM is less than 0,2 mm the prosthesis can 
be considering as stable, in a long run. Thirteen studies were enrolled to the MTPM analysis. 
The results showed that the MTPM values of the HA-coated cementless stems are 
significantly lower than that of the uncemented stems (WMD = 0.28, 95% CI: 0.01 - 0.56, P = 
0.045). When HA-coated implants were compared to cemented prostheses, the letter 
displayed lower MTPM (WMD = -0.29, 95% CI: -0.41 to 0.16, P < 0.001). 
4.3.2. Clinical outcomes
The secondary outcomes were KSS and KFS. 4 RCTs were enrolled to the analysis of 
clinical outcomes. The result showed that KSS of HA-coated cementless prostheses is no 
significantly higher as compared to the uncemented group (WMD = -0.64, 95% CI: -3.02 – 
1.73, P = 0.596). 
Of interest, there was no statistically significant difference in the KSS of HA-coated 
cementless and cemented prosthesis (WMD = -0.29, 95% CI: -2.27 to 1.69, P = 0.775). 
Similar results could be obtained by the analysis of KFS of studies, however, have limited 
value due to the lack of the comparison between HA-coated and uncemented groups. As such, 
no difference could be observed between HA-coated cementless and cemented implants 
(WMD = -4.95, 95% CI: -13.59 to 3.69 P = 0.069). However, comparison between HA-coated 
and uncemented groups could not have been done due to the low number of studies in the 
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uncemented group. KSS data are shown on the funnel plot, but unfortunatelly we couldn't run 
Egger's test on it.
5. DISCUSSION
5.1.Different mitochondrial functions in the synovia of RA and OA patients
This study provides quantitative clinical data on mitochondrial derangements in RA and 
OA. To be able to allocate our participants into our study groups adequately, the presence or 
lack of inflammatory states were confirmed by measuring pro-inflammatory cytokines in the 
synovial fluid samples of our patients. Additionally, histopathological evaluation and in vivo 
histology with CLSEM were also performed on tissue samples to detect the histological 
characteristics of RA and OA. Our results complied with the literature as RA patients had 
significantly higher levels of pro-inflammatory cytokines, hyperactive pathways of ROS 
production and displayed signs of chronic inflammation, neoangiogenesis and fibrosis by 
histopathology. 
The capacities of the ETC complexes in the study groups were tested with HRR. 
Interestingly, C I activity was strongly diminished in the RA group, while there was no 
significant difference in C II activity between the groups. This result highlights the central 
role of C I in mitochondrial dysfunction in RA, setting it as the main target of future RA 
therapies. C I is the first, largest, and most complicated component of the respiratory chain. 
Furthermore, as the major entry point for electrons to the respiratory chain, C I is considered 
as the rate-limiting factor in overall respiration. Additionally, it generates significant levels of 
ROS, especially during reverse electron transport. Compared to patients suffering from RA, 
members of the OA group displayed a milder, but still notable decrease in C I activity 
compared to healthy individuals in the control group. Again, a significant deficit in C II 
activity did not occur. 
5.2. Beneficial effects of EP delivery of diclofenac into the knee joint
This study has demonstrated the added value of EP to the transdermal delivery of 
diclofenac into the knee joint in experimental arthritis. The analgesic effect of EP-enhanced 
delivery was comparable to that of the oral administration and manifested in decreased 
nociceptive sensitivity, reduced joint swelling and lower cytokine concentration in the 
synovial fluid and lower inflammatory enzyme activities in the synovial tissue. The EP 
treatment also influenced the number of PMN–endothelial interactions at the level of the 
synovial microcirculation.
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In accordance with literature data, our results revealed that EP causes higher concentration 
values in the serum as compared with the topical administration. The diclofenac concentration 
in the synovia was equal to the serum concentrations; however, conventional topical treatment 
did not result in a detectable amount of diclofenac sodium in the synovial fluid.
Microcirculatory changes were investigated with IVM, and like other non-selective 
cyclooxygenase inhibitors, diclofenac diminishes the number of PMN–endothelial 
interactions when. Sticking in the synovial vessels was considerably reduced with the oral 
administration of diclofenac. However, it was only moderately ameliorated by the EP-
enhanced diclofenac hydrogel, and there were no changes in response to the simple topical 
application of the hydrogel.
Administration of C/K injection into the knee joint resulted in primary and secondary 
hyperalgesia in the inflammatory monoarthritis. Secondary hyperalgesia develops at the paw 
to heat and mechanical stimuli, and primary hyperalgesia is present over the inflamed knee 
joint. Secondary hyperalgesia reactions were investigated at the peak of the joint 
inflammation and both demonstrated a significant amelioration as a consequence of 
diclofenac treatment. Like the oral diclofenac treatment, EP completely restored thermal 
nociceptive sensitivity and increased mechanical touch sensitivity, but to a lesser extent. Knee 
swelling, which is an objective parameter of joint inflammation, was significantly reduced 
with both the oral and the EP-enhanced diclofenac treatment. Again, this increased volume 
was significantly reduced by both oral and EP-enhanced diclofenac treatments 48 h after 
arthritis induction.
Free radical formation has been demonstrated in the synovial fluid and synovial membrane 
under clinical conditions and proposed as a causative factor in joint disorders. Our present 
findings, demonstrated increases in XOR activity in response to arthritis attenuated by 
diclofenac treatment applied either in oral or simple topical routes of administration the latter 
being more accentuated in the case of EP. Data regarding the final step of PMN–endothelial 
interactions (i.e. sticking) were well correlated with the tissue accumulation of PMNs, as 
determined by MPO activity. Diclofenac treatment attenuated the MPO activity in the 
inflamed synovial tissue, applied either in oral or EP-enhanced topical routes of 
administration.
5.3. HA implants provide better fixation in TKA
This study reviews the current evidence and updates knowledge on the use of HA-coated 
tibial stem for primary TKA. The treatment groups were homogenous in terms of 
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characteristics of patients, thus the prediction of primary and secondary outcomes (i.e. MTPM 
and KSS and KFS) was likely independent from individual risk variables, patient selection or 
the overall severity of osteoporosis at prosthesis implantation. Direct meta-analysis 
comparison was made and the sample size of included trials was large enough to provide good 
evidence that HA-coating yields better stability than other, uncemented prostheses; However, 
cement fixation of prostheses stems still performs greater anchorage against migration. More 
importantly, the HA-coating is not outperformed by cemented prosthesis in providing good 
functional outcome with regards to pain intensity, range of motion and walking distance.
As a primary outcome of our study, the migration pattern of the prosthesis stems was 
determined as the maximum total point motion (MTPM) of the tibial stem measured by RSA. 
The MTPM value is the unit of measurement for the largest 3D migration of any point on the 
prosthesis surface. The migration pattern was defined as at least 2 postoperative follow-up 
moments within the first 2 years of follow-up. MTPM mainly depends on mechanical factors 
such as the bone-implant interface or different biological reactions at the implant-bone 
interface therefore is a reliable parameter to assess the added value of HA-coating in implant 
surface.
RCTs in our meta-analysis have demonstrated lower incidence of MTPM with HA–coated 
implants when compared other non-cemented stems, except one trial. As for the comparison 
of HA-coated cementless and cemented group, the overall rates of MTPM were very low in 
the cemented group and displayed lower incidence than HA-coated cementless prosthesis. 
Clinical outcomes, the KSS and KFS in our meta-analysis demonstrated equal functionality of 
HA-coated cementless and cemented implants. These scoring systems are validated and 
responsive methods for assessing objective and subjective outcomes after TKA. KSS is a 
weighted score which regards to pain intensity, range of motion, stability and flexion 
deformities, contractures and poor alignment.  The KFS considers mobility parameters of the 
patient such as the walking distance and stair climbing with deduction for walking aids. In 
spite of the predictive value of radiological stability, a recent meta-analysis has revealed the 
differences between postoperative radiological and clinical performance of TKAs at the same 
time. 
6. SUMMARY OF NEW FINDINGS 
Our findings provided supportive data for the mitochondrial involvement in the 
pathomechanism of OA and RA.  We have shown, for the first time that despite of similarities 
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in the clinical picture, the mitochondrial dysfunction substantially different in OA and RA. 
We have demonstrated the decisive role of Complex I and disruption of the ETC integrity in 
the inner mitochondrial membrane. 
We have demonstrated improved drug delivery with EP in the conservative treatment of 
arthritis. We have confirmed the direct action of EP-enhanced transdermal diclofenac sodium 
delivery on the synovial microcirculation as proven by the decreased rolling and the reduced 
sticking of leukocytes. The biochemical measurements also demonstrated that diclofenac 
achieved an efficient tissue concentration in the synovium since inflammatory enzyme 
activities decreased. In summary, EP-enhanced transdermal diclofenac sodium delivery 
attenuated the microcirculatory deterioration and the consecutive stages of tissue 
inflammation; therefore, this type of mechanism might be an interesting focus for therapeutic 
strategies in arthritis. 
Our review on implants outcomes provided the best available evidence that HA-coated 
cementless prosthesis outperforms other cementless prostheses both in respect to stability and 
functionality. Cemented fixation of prostheses provides the best stability in a 2-year follow 
up, however, functional results are not superior to HA-coated cementless fixation. Based on 
these results, HA-coated cementless TKA is a recommended option for treating end-stage 
arthritis of the knee, and clinicians consider together with patients the factors associated with 
the risk of revision when choosing the most appropriate procedure.
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